During JPM week, virtual care companies strut their plans to make GLP-1 drugs work harder, cost less
Digital health companies' plans focused on managing the impact of GLP-1 drugs, which have placed enormous pressure on health ...
51mOpinion
Until two years ago, such discussion was of little practical relevance, since there were few treatments for obesity between ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback